A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Immtech International Inc.

About Immtech International Inc:

Immtech International Inc. is a pharmaceutical company focused on commercializing a new class of oral drugs to treat infectious diseases.

Immtech is developing oral drugs to treat infectious diseases such as pneumonia, fungal infections ($4 billion annual sales), malaria (affecting 2 billion people and causing 2 million deaths annually), tuberculosis (affecting 2 billion people and causing 2 million deaths annually), diabetes (affecting 170 million people), hepatitis ($2 billion annual sales); and tropical diseases such as African sleeping sickness (affecting 60 million people), and Leishmania (prevalent in 80 countries).


More on Immtech

Home Page

Key Statistics for Immtech

Basic Chart for Immtech

Analyst Opinion

Analysts Estimates

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.